Healthcare provider profile · identity verified

Uchenna Dike, MD

Internal Medicine · GREENVILLE, SC · NPI 1275564171

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	96	34
Atorvastatin Calcium	Atorvastatin Calcium	94	39
Tramadol Hcl	Tramadol Hcl	79	15
Pravastatin Sodium	Pravastatin Sodium	78	22
Amlodipine Besylate	Amlodipine Besylate	73	33
Omeprazole	Omeprazole	69	22
Metformin Hcl Er	Metformin Hcl	67	25
Shingrix	Varicella-Zoster Ge/As01b/Pf	59	48
Olmesartan Medoxomil	Olmesartan Medoxomil	58	19
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	55	19
Trazodone Hcl	Trazodone Hcl	54	14
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	52	50
Gabapentin	Gabapentin	52	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	45	15
Tamsulosin Hcl	Tamsulosin Hcl	45	13
Alprazolam	Alprazolam	44	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	43	15
Meloxicam	Meloxicam	42	15
Metoprolol Succinate	Metoprolol Succinate	42	15
Lorazepam	Lorazepam	39	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	14
Lisinopril	Lisinopril	32	13
Rosuvastatin Calcium	Rosuvastatin Calcium	32	13
Furosemide	Furosemide	27	14
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Ozempic	Semaglutide	26	suppressed
Famotidine	Famotidine	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	suppressed
Losartan Potassium	Losartan Potassium	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	18
Combivent Respimat	Ipratropium/Albuterol Sulfate	23	suppressed
Sertraline Hcl	Sertraline Hcl	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Metformin Hcl	Metformin Hcl	21	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Potassium Chloride	Potassium Chloride	21	11
Donepezil Hcl	Donepezil Hcl	20	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	19	suppressed
Azithromycin	Azithromycin	18	17
Celecoxib	Celecoxib	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Levofloxacin	Levofloxacin	16	15
Linzess	Linaclotide	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Simvastatin	Simvastatin	15	suppressed
Valsartan	Valsartan	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Glipizide	Glipizide	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Amoxicillin	Amoxicillin	13	suppressed
Carvedilol	Carvedilol	13	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Labetalol Hcl	Labetalol Hcl	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Atenolol	Atenolol	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Diazepam	Diazepam	11	suppressed
Eliquis	Apixaban	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error